Lives of the fellows

Michael Victor Zammit-Tabona

b.27 July 1950 d.16 August 2015
MB BChir Cantab(1975) MRCP(1978) DPM(1986) MFPM(1989) FRCP(2009)

Michael Victor Zammit-Tabona was a consultant in pharmaceutical medicine. He was born in Malta, the son of Victor and Marcelle Zammit-Tabona, both physicians. He attended school in Baghdad and New York, and then the International School of Geneva, Switzerland. He went on to study medicine at Churchill College, University of Cambridge and Westminster Medical School, qualifying in 1975.

He was a house physician at Westminster Hospital and then a house surgeon (and subsequently a research fellow) at Northwick Park Hospital, Middlesex. From 1977 to 1979, he was a senior house officer in general medicine at Kent and Canterbury Hospital. He was then a registrar in general and respiratory medicine at the Royal Postgraduate Medical School, Hammersmith Hospital, London.

From August 1981 to August 1982 he was a post-doctoral research fellow in respiratory medicine at the University of British Columbia.

On his return to the UK, he became a locum senior registrar in general medicine, diabetes and endocrinology at the Middlesex Hospital, London. From February 1983 to February 1984 he was a locum consultant in respiratory medicine at Ealing General Hospital and St Mary’s Hospital Medical School, London.

From March 1984 he based his career in the pharmaceutical industry, initially as a clinical research physician in the European medical department at the Lilly Research Centre. In July 1987 he joined Beecham Pharmaceuticals (which later became SmithKline Beecham). He was director and vice president of the general medicine and anti-infective therapeutic unit, HQ clinical research and development and medical affairs, until December 1990. From 1991 to 1993 he was medical director and vice president for Europe, clinical research and development and medical affairs, and then director and vice president of the inflammation, tissue repair and oncology therapeutic team, clinical research and development and medical affairs Europe. He subsequently moved to the cardio-pulmonary and diabetes therapeutic team. From 2000 to 2001 he was a member of a small integration team which planned the global merger between Glaxo Wellcome and SmithKline Beecham to form GlaxoSmithKline.

He then became an independent consultant in pharmaceutical medicine, investment and strategy management and (from January 2004) an honorary fellow at the Cambridge University hospitals.

Outside medicine, he enjoyed spending time with his family, travel, French and Spanish literature and skiing.

He was married to Christine and they had three sons – Robin, Jonathan and Oliver. He died at the age of 65 four months after being diagnosed with a terminal brain tumour.

RCP editor

[International School of Geneva. News & Blogs: In Memoriam – accessed 16 October 2017]

(Volume XII, page web)

<< Back to List